|
⚲
|
| Keyboard |
| Malik Kemal
✚
|
|
|---|---|
| CIK # | 0001797921 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001797921] | |
| 4 | [0001797921] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Malik Kemal | |
| Selecta Biosciences Inc | |
| Acceleron Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Selecta Biosciences Inc RNAC
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 7,800 | $0.00 | |
|
Selecta Biosciences Inc RNAC
Common Stock
|
2026-01-02 | Grant | 2,600 | $0.00 | |
|
Selecta Biosciences Inc RNAC
Common Stock
|
2025-01-02 | Grant | 2,600 | $0.00 | |
|
Selecta Biosciences Inc RNAC
Stock Option (Right to Buy) · derivative
|
2025-01-02 | Grant | 7,800 | $0.00 | |
|
Selecta Biosciences Inc RNAC
Common Stock
|
2024-07-01 | Grant | 5,933 | $0.00 | |
|
Selecta Biosciences Inc RNAC
Stock Option (Right to Buy) · derivative
|
2024-07-01 | Grant | 7,600 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-11-19 | Tender | 1,622 | ||
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 3,222 | ||
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 17,956 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-01-29 | Grant | 1,622 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-01-29 | Grant | 3,222 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2020-01-02 | Grant | 17,567 | $0.00 |